CARBAMAZEPINE
- Product NDC
- 60432-129
- 11-digit product format
- 604320129
- Labeler code
- 60432
- Product ID
- 60432-129_187523ab-0aff-4b96-9677-b3909a620213
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- carbamazepine
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Morton Grove Pharmaceuticals, Inc.
- Application
- ANDA075714
- Marketing category
- ANDA
- Marketing start
- 2002-06-05
- Marketing end
- 0000-00-00
- Substance
- CARBAMAZEPINE
- Active strength
- 100 mg/5mL
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Carbamazepine | ACTIVE INGREDIENT | 33CM23913M | CARBAMAZEPINE SUSPENSION [MORTON GROVE PHARMACEUTICALS, INC.] | 9 | |
| Carbamazepine | ACTIVE MOIETY | 33CM23913M | CARBAMAZEPINE SUSPENSION [MORTON GROVE PHARMACEUTICALS, INC.] | 9 | |
| Anhydrous Citric Acid | INACTIVE INGREDIENT | XF417D3PSL | CARBAMAZEPINE SUSPENSION [MORTON GROVE PHARMACEUTICALS, INC.] | 9 | |
| Citric Acid Monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | CARBAMAZEPINE SUSPENSION [MORTON GROVE PHARMACEUTICALS, INC.] | 9 | |
| FD&C Yellow No. 6 | INACTIVE INGREDIENT | H77VEI93A8 | CARBAMAZEPINE SUSPENSION [MORTON GROVE PHARMACEUTICALS, INC.] | 9 | |
| Hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | CARBAMAZEPINE SUSPENSION [MORTON GROVE PHARMACEUTICALS, INC.] | 9 | |
| Potassium Sorbate | INACTIVE INGREDIENT | 1VPU26JZZ4 | CARBAMAZEPINE SUSPENSION [MORTON GROVE PHARMACEUTICALS, INC.] | 9 | |
| Propylene Glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | CARBAMAZEPINE SUSPENSION [MORTON GROVE PHARMACEUTICALS, INC.] | 9 | |
| Sodium Citrate | INACTIVE INGREDIENT | 1Q73Q2JULR | CARBAMAZEPINE SUSPENSION [MORTON GROVE PHARMACEUTICALS, INC.] | 9 | |
| Sorbitol | INACTIVE INGREDIENT | 506T60A25R | CARBAMAZEPINE SUSPENSION [MORTON GROVE PHARMACEUTICALS, INC.] | 9 | |
| Sucrose | INACTIVE INGREDIENT | C151H8M554 | CARBAMAZEPINE SUSPENSION [MORTON GROVE PHARMACEUTICALS, INC.] | 9 | |
| Vanillin | INACTIVE INGREDIENT | CHI530446X | CARBAMAZEPINE SUSPENSION [MORTON GROVE PHARMACEUTICALS, INC.] | 9 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | CARBAMAZEPINE SUSPENSION [MORTON GROVE PHARMACEUTICALS, INC.] | 9 | |
| Xanthan Gum | INACTIVE INGREDIENT | TTV12P4NEE | CARBAMAZEPINE SUSPENSION [MORTON GROVE PHARMACEUTICALS, INC.] | 9 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60432-129 | CARBAMAZEPINE SUSPENSION [MORTON GROVE PHARMACEUTICALS, INC.] | 14 | Legacy NDC | 20181222_99e20867-a5eb-4474-b846-619ee45f40b8.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60432-129-16 | 60432012916 | 450 mL in 1 BOTTLE, PLASTIC (60432-129-16) | 450 ml | 2002-06-05 | 0000-00-00 | No | No | Current |